Price Chart

Profile

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
URL https://www.criver.com
Investor Relations URL https://ir.criver.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release May. 10, 2024 (est.)
Last Earnings Release Feb. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
URL https://www.criver.com
Investor Relations URL https://ir.criver.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release May. 10, 2024 (est.)
Last Earnings Release Feb. 14, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A